Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

other Versions

You are currently viewing an earlier version of this article (April 09, 2020).
latest version (April 30, 2020).
latest version (June 08, 2020).
View the most recent version of this article

Review

Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events

Online download statistics by month:

Online download statistics by month: April 2020 to May 2021

	Abstract	Full	Pdf
Apr 2020	589	578	364
May 2020	641	634	355
Jun 2020	373	367	177
Jul 2020	1447	1436	410
Aug 2020	341	334	93
Sep 2020	400	390	87
Oct 2020	237	227	80
Nov 2020	217	210	78
Dec 2020	200	193	103
Jan 2021	202	195	78
Feb 2021	155	151	63
Mar 2021	259	257	86
Apr 2021	174	160	63
May 2021	24	23	8
Total	5259	5155	2045